Patent intelligence · US
US 11433025
Oil foamable carriers and formulations
Oil foamable carriers and formulations
Patent details — US 11433025
- Jurisdiction
- US
- Status
- granted
- Grant date
- Sep 6, 2022
- Expiration
- Sep 1, 2042
- Applicant
- Vyne Therapeutics Inc.
- Claims
- 14
- CPC classes
- A61K, A61K31/20, A61K31/355, A61K31/522
Quick answer
US 11433025 (Oil foamable carriers and formulations) is held by Vyne Therapeutics Inc.. Status: granted. Granted Sep 6, 2022. Expires Sep 1, 2042 (16 years remaining) — relevant for patent-cliff and LOE planning.
Key facts
- Applicant
- Vyne Therapeutics Inc.
- Grant date
- Expiration
- Claims
- 14
- CPC classes
- A61K, A61K31/20, A61K31/355, A61K31/522, A61K31/59, A61K31/65
More from Vyne Therapeutics Inc.
Related pharmaceutical patents in our USPTO index.
-
US 11219631
Foamable compositions, breakable foams and their uses
granted -
US 11103454
Wax foamable vehicle and pharmaceutical compositions thereof
granted -
US 11033491
Dicarboxylic acid foamable vehicle and pharmaceutical compositions thereof
granted -
US 11026920
Use of NK-1 receptor antagonist serlopitant in pruritus
granted -
US 10967063
Surfactant-free, water-free formable composition and breakable foams and their uses
granted -
US 10946101
Surfactant-free water-free foamable compositions, breakable foams and gels and their uses
granted
Frequently asked questions
What is US patent 11433025?
US 11433025 (Oil foamable carriers and formulations) is held by Vyne Therapeutics Inc.. Status: granted. Granted Sep 6, 2022. Expires Sep 1, 2042 (16 years remaining) — relevant for patent-cliff and LOE planning.
Who owns US 11433025?
Vyne Therapeutics Inc. is listed as the applicant in USPTO PatentsView records indexed by NovaPharmaNews. We track 7 pharmaceutical patents for this assignee.
When does US 11433025 expire?
Our index shows an expiration date of Sep 1, 2042 (16 years from today). Confirm material dates against USPTO, FDA Orange Book, or qualified counsel before contractual decisions.